The relationship of hepatic tissue oxygenation with nitric oxide metabolism in ischemic preconditioning of the liver.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMID 12207003)

Published in FASEB J on August 07, 2002

Authors

Rahul S Koti1, Alexander M Seifalian, Alan G McBride, Wenxuan Yang, Brian R Davidson

Author Affiliations

1: University Department of Surgery and Liver Transplantation Unit, Royal Free and University College Medical School, University College London, Royal Free Hospital, London, UK.

Articles citing this

Ischemia-reperfusion injury of the intestine and protective strategies against injury. Dig Dis Sci (2004) 2.54

Molecular mechanisms of liver preconditioning. World J Gastroenterol (2010) 1.06

Effect of remote ischemic preconditioning on hepatic microcirculation and function in a rat model of hepatic ischemia reperfusion injury. HPB (Oxford) (2009) 0.97

Current protective strategies in liver surgery. World J Gastroenterol (2010) 0.88

Modulation of microcirculatory changes in the late phase of hepatic ischaemia-reperfusion injury by remote ischaemic preconditioning. HPB (Oxford) (2011) 0.88

Ischemic preconditioning accelerates muscle deoxygenation dynamics and enhances exercise endurance during the work-to-work test. Physiol Rep (2015) 0.87

How to protect liver graft with nitric oxide. World J Gastroenterol (2011) 0.85

Acute effects of remote ischemic preconditioning on cutaneous microcirculation--a controlled prospective cohort study. BMC Surg (2011) 0.83

Polydatin, a natural precursor of resveratrol, induces cell cycle arrest and differentiation of human colorectal Caco-2 cell. J Transl Med (2013) 0.82

Conventional, but not remote ischemic preconditioning, reduces iNOS transcription in liver ischemia/reperfusion. World J Gastroenterol (2014) 0.80

Role of ischaemic preconditioning in liver regeneration following major liver resection and transplantation. World J Gastroenterol (2007) 0.77

Influence of Kupffer cells on hepatic signal transduction as demonstrated by second messengers and nuclear transcription factors. World J Gastroenterol (2003) 0.75

Effects of Remote Ischemic Conditioning Methods on Ischemia-Reperfusion Injury in Muscle Flaps: An Experimental Study in Rats. Arch Plast Surg (2017) 0.75

Monophosphoryl lipid A-induced delayed preconditioning in rat small intestine is mediated by calcitonin gene-related peptide. Dig Dis Sci (2010) 0.75

Articles by these authors

Cholangiocarcinoma. Lancet (2005) 6.01

Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study. Lancet (2012) 4.54

Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut (2012) 2.91

Ischemia-reperfusion injury of the intestine and protective strategies against injury. Dig Dis Sci (2004) 2.54

Nanosilver as a new generation of nanoproduct in biomedical applications. Trends Biotechnol (2010) 2.41

Biological applications of quantum dots. Biomaterials (2007) 2.22

The contemporary role of antioxidant therapy in attenuating liver ischemia-reperfusion injury: a review. Liver Transpl (2005) 2.04

Gallstones. BMJ (2014) 2.02

Properties of the amniotic membrane for potential use in tissue engineering. Eur Cell Mater (2008) 2.01

Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci (2009) 1.98

Virtual reality training for surgical trainees in laparoscopic surgery. Cochrane Database Syst Rev (2009) 1.88

Remote ischemic preconditioning: a novel protective method from ischemia reperfusion injury--a review. J Surg Res (2008) 1.81

Early versus delayed laparoscopic cholecystectomy for biliary colic. Cochrane Database Syst Rev (2008) 1.77

The roles of tissue engineering and vascularisation in the development of micro-vascular networks: a review. Biomaterials (2005) 1.75

Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study. Liver Transpl (2007) 1.68

Immunosuppression and donor age with respect to severity of HCV recurrence after liver transplantation. Liver Transpl (2005) 1.58

Silsesquioxane nanocomposites as tissue implants. Plast Reconstr Surg (2007) 1.56

Current status of prosthetic bypass grafts: a review. J Biomed Mater Res B Appl Biomater (2005) 1.56

Endometrial stem cell differentiation into smooth muscle cell: a novel approach for bladder tissue engineering in women. BJU Int (2013) 1.46

Tumor M2-pyruvate kinase as tumor marker in exocrine pancreatic cancer a meta-analysis. Pancreas (2007) 1.45

Methods of preventing bacterial sepsis and wound complications for liver transplantation. Cochrane Database Syst Rev (2008) 1.41

Polymeric heart valves: new materials, emerging hopes. Trends Biotechnol (2009) 1.41

Early versus delayed laparoscopic cholecystectomy for people with acute cholecystitis. Cochrane Database Syst Rev (2013) 1.40

Low pressure versus standard pressure pneumoperitoneum in laparoscopic cholecystectomy. Cochrane Database Syst Rev (2009) 1.39

Day-case versus overnight stay for laparoscopic cholecystectomy. Cochrane Database Syst Rev (2008) 1.33

Polyhedral oligomeric silsesquioxane nanocomposites: the next generation material for biomedical applications. Acc Chem Res (2005) 1.31

The role of the insulin-like growth factor system in colorectal cancer: review of current knowledge. Int J Colorectal Dis (2005) 1.30

Biomaterials and scaffold design: key to tissue-engineering cartilage. Biotechnol Appl Biochem (2007) 1.27

Biofunctionalization of biomaterials for accelerated in situ endothelialization: a review. Biomacromolecules (2008) 1.27

Virtual reality training for surgical trainees in laparoscopic surgery. Cochrane Database Syst Rev (2013) 1.23

Protocols and mechanisms for remote ischemic preconditioning: a novel method for reducing ischemia reperfusion injury. Transplantation (2007) 1.22

Protection of the liver by ischemic preconditioning: a review of mechanisms and clinical applications. Dig Surg (2003) 1.21

Techniques for liver parenchymal transection in liver resection. Cochrane Database Syst Rev (2009) 1.21

A new era of cancer treatment: carbon nanotubes as drug delivery tools. Int J Nanomedicine (2011) 1.20

The application of exosomes as a nanoscale cancer vaccine. Int J Nanomedicine (2010) 1.18

Biology of insulin-like growth factor binding protein-4 and its role in cancer (review). Int J Oncol (2006) 1.16

Methods to decrease blood loss and transfusion requirements for liver transplantation. Cochrane Database Syst Rev (2011) 1.15

Tumour M2-pyruvate kinase: a gastrointestinal cancer marker. Eur J Gastroenterol Hepatol (2007) 1.13

Advancing cartilage tissue engineering: the application of stem cell technology. Curr Opin Biotechnol (2005) 1.13

Clinical potential of quantum dots. J Biomed Biotechnol (2007) 1.12

Vascular risk factors in South Asians. Int J Cardiol (2008) 1.11

Day-surgery versus overnight stay surgery for laparoscopic cholecystectomy. Cochrane Database Syst Rev (2013) 1.11

In situ endothelialization potential of a biofunctionalised nanocomposite biomaterial-based small diameter bypass graft. Biomed Mater Eng (2009) 1.10

Impairment of hepatic microcirculation in fatty liver. Microcirculation (2003) 1.10

Exosomes as nano-theranostic delivery platforms for gene therapy. Adv Drug Deliv Rev (2012) 1.10

Apoptosis and colorectal cancer: implications for therapy. Trends Mol Med (2009) 1.09

Modern surgical management of peripheral nerve gap. J Plast Reconstr Aesthet Surg (2010) 1.09

Cardiovascular application of polyhedral oligomeric silsesquioxane nanomaterials: a glimpse into prospective horizons. Int J Nanomedicine (2011) 1.09

Somatostatin analogues for pancreatic surgery. Cochrane Database Syst Rev (2013) 1.08

Percutaneous cholecystostomy for high-risk surgical patients with acute calculous cholecystitis. Cochrane Database Syst Rev (2013) 1.08

Molecular mechanisms of liver ischemia reperfusion injury: insights from transgenic knockout models. World J Gastroenterol (2013) 1.07

Stem cells and cancer: an overview. Stem Cell Rev (2007) 1.07

Toxicology and clinical potential of nanoparticles. Nano Today (2011) 1.05

Low pressure versus standard pressure pneumoperitoneum in laparoscopic cholecystectomy. Cochrane Database Syst Rev (2014) 1.04

Nerve conduits for peripheral nerve surgery. Plast Reconstr Surg (2014) 1.04

Meta-analysis of randomized controlled trials on the effectiveness of somatostatin analogues for pancreatic surgery: a Cochrane review. HPB (Oxford) (2010) 1.04

Pre-operative biliary drainage for obstructive jaundice. Cochrane Database Syst Rev (2012) 1.03

Immunomodulatory effect of a decellularized skeletal muscle scaffold in a discordant xenotransplantation model. Proc Natl Acad Sci U S A (2013) 1.03

Tissue engineering of small intestine--current status. Biomacromolecules (2006) 1.01

Effect of graduated compression stockings on limb oxygenation and venous function during exercise in patients with venous insufficiency. Vascular (2004) 1.01

Functionalization of single-walled carbon nanotubes and their binding to cancer cells. Int J Nanomedicine (2012) 1.00

Fluorescence nanoparticles "quantum dots" as drug delivery system and their toxicity: a review. J Drug Target (2010) 0.99

Achieving the ideal properties for vascular bypass grafts using a tissue engineered approach: a review. Med Biol Eng Comput (2007) 0.98

Early versus delayed laparoscopic cholecystectomy for uncomplicated biliary colic. Cochrane Database Syst Rev (2013) 0.98

Liver transplantation and recurrent hepatocellular carcinoma: predictive value of nodule size in a retrospective and explant study. Transplantation (2006) 0.98

Outcome of early endoscopic biliary drainage in the management of bile leaks after hepatic resection. Gastrointest Endosc (2003) 0.97

Effect of remote ischemic preconditioning on hepatic microcirculation and function in a rat model of hepatic ischemia reperfusion injury. HPB (Oxford) (2009) 0.97

The antithrombogenic potential of a polyhedral oligomeric silsesquioxane (POSS) nanocomposite. Biomacromolecules (2006) 0.97

Laparoscopic surgical box model training for surgical trainees with no prior laparoscopic experience. Cochrane Database Syst Rev (2014) 0.96

Methods of vascular occlusion for elective liver resections. Cochrane Database Syst Rev (2009) 0.96

Small calibre polyhedral oligomeric silsesquioxane nanocomposite cardiovascular grafts: influence of porosity on the structure, haemocompatibility and mechanical properties. Acta Biomater (2011) 0.96

The degradative resistance of polyhedral oligomeric silsesquioxane nanocore integrated polyurethanes: an in vitro study. Biomaterials (2005) 0.96

The use of animal models in developing the discipline of cardiovascular tissue engineering: a review. Biomaterials (2004) 0.96

Evaluation of the POSSUM scoring system for comparative audit in pancreatic surgery. Dig Surg (2003) 0.95

A review of the carotid and femoral intima-media thickness as an indicator of the presence of peripheral vascular disease and cardiovascular risk factors. Cardiovasc Res (2002) 0.95

Nitric oxide: a guardian for vascular grafts? Chem Rev (2011) 0.95

Quantitating therapeutic disruption of tumor blood flow with intravital video microscopy. Cancer Res (2006) 0.95

Surgical treatment of gallstones. Gastroenterol Clin North Am (2010) 0.95

Liver resection versus other treatments for neuroendocrine tumours in patients with resectable liver metastases. Cochrane Database Syst Rev (2009) 0.95

A nanocage for nanomedicine: polyhedral oligomeric silsesquioxane (POSS). Macromol Rapid Commun (2011) 0.95

Intima-media thickness of elastic and muscular arteries of young women with polycystic ovaries. Atherosclerosis (2004) 0.95

Tissue engineering: revolution and challenge in auricular cartilage reconstruction. Plast Reconstr Surg (2012) 0.94

Manufacturing and hydrodynamic assessment of a novel aortic valve made of a new nanocomposite polymer. J Biomech (2012) 0.94

The endothelialization of polyhedral oligomeric silsesquioxane nanocomposites: an in vitro study. Cell Biochem Biophys (2006) 0.93

Advancing vascular tissue engineering: the role of stem cell technology. Trends Biotechnol (2005) 0.93

Systematic review of randomized controlled trials of pharmacological interventions to reduce ischaemia-reperfusion injury in elective liver resection with vascular occlusion. HPB (Oxford) (2010) 0.93

Development of a hybrid cardiovascular graft using a tissue engineering approach. FASEB J (2002) 0.93

Cholecystectomy for gallbladder polyp. Cochrane Database Syst Rev (2009) 0.93

In vitro small intestinal epithelial cell growth on a nanocomposite polycaprolactone scaffold. Biotechnol Appl Biochem (2009) 0.93

Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer. Cochrane Database Syst Rev (2013) 0.92

Wound infiltration with local anaesthetic agents for laparoscopic cholecystectomy. Cochrane Database Syst Rev (2014) 0.92